investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Pharmacogenetics of Nicotine Addiction Treatment
Caryn Lerman
1 Collaborator(s)
Funding source
National Institute on Drug Abuse (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Rachel Tyndale
University of Toronto
Toronto, Canada
Caryn Lerman
University of Pennsylvania
Philadelphia, United States
Related projects
Charles Vinson
Gene Regulation and Function: The B-ZIP Proteins – Rockville
All cancers but non-melanoma skin cancer
Alan Perantoni
Growth/Differentiation Factors in OrganogenesisÂ
All cancers but non-melanoma skin cancer
Karlene A Cimprich
Regulation of the DNA Damage Response
All cancers but non-melanoma skin cancer
Ronald Wayne Davis
Revolutionizing Biomedical and Clinical Research through Innovative Technology
All cancers but non-melanoma skin cancer
Sun Hur
Structural and functional analyses of the RIG-I filament in innate immunity
All cancers but non-melanoma skin cancer
Deborah Johnson
Novel targets that are deregulated by loss of PTEN
All cancers but non-melanoma skin cancer
Steen Henning Hansen
Defining oncogenic capacities of PAK7 mutations in human cancer
All cancers but non-melanoma skin cancer
Xingxing Zang
The B7x pathway in the tumor microenvironment
All cancers but non-melanoma skin cancer
Chantal Guillemette
Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)
All cancers but non-melanoma skin cancer